Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Fallopian Tube Neoplasms × cediranib × Clear all

Phase

Status

Active not recruiting 4 Completed 3 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinosarcoma 1

Interventions

Paclitaxel 16 Carboplatin 15 Bevacizumab 5 Taxes 3 Hyperthermic Intraperitoneal Chemotherapy 3 Gemcitabine 3 Cisplatin 3 Chemotherapy, Adjuvant 3 pembrolizumab 2 oregovomab 2 niraparib 2 fluzoparib 2 Topotecan 2 ST 1481 2 Neoadjuvant Therapy 2 Methods 2 Immunohistochemistry 2 Ifosfamide 2 Gene Expression Profiling 2 Filgrastim 2 Educational Status 2 Early Intervention, Educational 2 Cytoreduction Surgical Procedures 2 Amplified Fragment Length Polymorphism Analysis 2 rucaparib 1 paclitaxel poliglumex 1 olaparib 1 navicixizumab 1 mirvetuximab soravtansine 1 liposomal doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00532194 2015-09-23

ICON6

Medical Research Council

Phase 3 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡